Further work may elucidate circadian impacts on select patients, tumors, and therapies; however, we found no significant effect in this study.
Keyphrases
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- squamous cell carcinoma
- early stage
- small cell lung cancer
- peritoneal dialysis
- clinical trial
- study protocol
- radiation therapy
- prognostic factors
- randomized controlled trial
- patient reported outcomes
- locally advanced
- phase ii
- patient reported
- rectal cancer
- double blind